HB6220, the MIRACLE Act of 2025, directs the Secretary of Health and Human Services to conduct a study on neonatal abstinence syndrome (NAS) and to report the findings to Congress within three years. The study must examine the prevalence of NAS and infant and maternal health outcomes associated with pediatric transitional care facilities, which the bill defines as residential pediatric recovery centers for infants with NAS that provide inpatient or outpatient treatment.
The bill also requires HHS to identify barriers to obtaining valid, accurate, and current data on NAS prevalence among Medicaid beneficiaries under state plans or waivers under Title XIX of the Social Security Act. In addition, HHS must assess the scope of services and supports available to beneficiaries diagnosed with NAS under those state Medicaid programs or waivers. After submission to Congress, the report must be made publicly available on a website.
Impact
The bill does not directly change Medicaid eligibility, benefits, or state program requirements, but it would create a federal research and reporting mandate focused on NAS and related care settings. Its practical impact would be to generate federal findings on data gaps, service availability, and outcomes for infants and mothers, especially within state Medicaid programs and waiver arrangements. The bill could influence future state and federal policy by identifying inconsistencies in data collection and care access, and by informing later legislation or administrative action.
Sentiment
Based on the bill text and the limited available context, the bill appears to be framed as a bipartisan, research-oriented measure focused on infant health and substance-use-related care. The sponsors include members from both parties, which suggests broad interest in studying the issue rather than advancing a partisan policy change. There is no recorded committee debate or vote history in the provided materials, so there is no evidence of formal opposition or support beyond the bill’s introduction and referral.
Contention
The main potential points of contention are likely to be the bill’s focus on Medicaid data collection, the role of state plans and waivers, and the definition and use of pediatric transitional care facilities. Stakeholders concerned about federal oversight may question the burden of data reporting or the implications for state Medicaid administration, while advocates for infant and maternal health may support the study as a way to improve outcomes and identify service gaps. Because no committee transcript or vote is provided, no specific objections or supporters are identified in the record here.
MIRACLE Medical Technology Act of 2025 Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025
Directing the Joint State Government Commission to establish an advisory committee and conduct a comprehensive study regarding the effectiveness of the Commonwealth's multidisciplinary approach to infants born affected by substance use or withdrawal symptoms resulting from prenatal drug exposure or a fetal alcohol spectrum disorder, including the success with or barriers to developing plans of safe care as required by Federal and State law.